Detalhe da pesquisa
1.
Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis.
J Immunol
; 182(12): 8104-9, 2009 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19494336